» Articles » PMID: 36908063

Genitourinary Syndrome in Menopause: Impact of Vaginal Symptoms

Overview
Date 2023 Mar 13
PMID 36908063
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the impact of genitourinary syndrome symptoms on daily activities and well-being in peri- and postmenopausal women living in an urban area.

Materials And Methods: Observational, prospective, and cross-sectional research in a population of peri- and postmenopausal women living in the Lima region. A non-probabilistic sample was used. The instrument used is "The Day-to-Day Impact of Vaginal Aging" questionnaire. It consists of four domains and its internal reliability is between 0.82 and 0.93. The questions were answered using a Likert scale. High values indicate a more severe impact. Statistical procedures were performed using SPSS version 26.

Results: One thousand seventy women participated; the mean age was 54±7.5 years. The results about the activities of daily living showed that 35% of women reported regular vaginal symptoms and 14.7% major symptoms. In the emotional well-being domain, 90% had minor symptoms. In the sexual function domain, 57.6% reported minor vaginal symptoms, and in the self-concept and body image domain, 60.9% reported minor symptoms and 20.7% major symptoms. According to the global score, 60.9% reported minor discomfort, 36.3% regular discomfort, and 2.8% major discomfort. The sexually active women declared an impact of severity in terms of their daily activities and sexual function (p<0.05).

Conclusion: There is a relationship between activities of daily living, sexual function, and women with sexual activity, causing a negative impact on social life and quality of life.

Citing Articles

Understanding the Benefits of CO Laser Treatment for Vulvovaginal Atrophy.

Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M Medicina (Kaunas). 2024; 60(7).

PMID: 39064488 PMC: 11279000. DOI: 10.3390/medicina60071059.

References
1.
Mitchell C, Ma N, Mitchell A, Wu M, Valint D, Proll S . Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation. Am J Obstet Gynecol. 2021; 225(2):159.e1-159.e15. PMC: 8328873. DOI: 10.1016/j.ajog.2021.02.034. View

2.
Shifren J, Zincavage R, Cho E, Magnavita A, Portman D, Krychman M . Women's experience of vulvovaginal symptoms associated with menopause. Menopause. 2018; 26(4):341-349. DOI: 10.1097/GME.0000000000001275. View

3.
Dennerstein L, Dudley E, Hopper J, Guthrie J, Burger H . A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000; 96(3):351-8. DOI: 10.1016/s0029-7844(00)00930-3. View

4.
Huang A, Gregorich S, Kuppermann M, Nakagawa S, Van Den Eeden S, Brown J . Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause. 2014; 22(2):144-54. PMC: 4280352. DOI: 10.1097/GME.0000000000000281. View

5.
Nappi R, Kokot-Kierepa M . Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey. Climacteric. 2011; 15(1):36-44. DOI: 10.3109/13697137.2011.647840. View